国新健康: 2025年半年度业绩预告

Performance Forecast - The company expects a revenue of approximately 100.13 million yuan for the reporting period, down from 137.39 million yuan in the same period last year [1] - The net profit attributable to shareholders is projected to be a loss of about 89.21 million yuan, compared to a loss of 72.98 million yuan in the previous year [1] - The basic earnings per share is estimated to be a loss of approximately 0.0911 yuan per share, compared to a loss of 0.0745 yuan per share in the prior year [1] Revenue and Profit Analysis - The company reported a decrease in both operating revenue and net profit, indicating a challenging financial environment [1] - The revenue for the current period is approximately 10,013 million yuan, while the adjusted operating revenue is about 10,005 million yuan [1] - The net profit after deducting non-recurring gains and losses is also projected to be a loss of around 88.91 million yuan, compared to a loss of 78.37 million yuan in the previous year [1] Strategic Focus - The company is aligning its operations with the "Healthy China" initiative and the "Three Medical Collaborations" reform, focusing on health data integration and digital transformation [1] - The strategic direction emphasizes the value of health big data and aims to enhance services in medical insurance fund management, medical quality safety, and health service innovation [1] - The company aims to continuously optimize and improve its product system to adapt to the evolving healthcare landscape [1]